COMPANY
Teva Pharmaceuticals USA, Inc
Teva Pharmaceuticals USA, Inc: US labeler, recalling firm for Icatibant, Liraglutide, Teriparatide, Octreotide, as stated by public registers.
Also written as: Teva Pharmaceuticals USA, Inc..
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Icatibant | Icatibant, ANDA Regulator openFDA |
|---|---|
| Liraglutide | Liraglutide, NDA AUTHORIZED GENERIC Regulator openFDA |
| Teriparatide | Teriparatide, ANDA Regulator openFDA |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Octreotide | Class II recall, Ongoing, 2026-04-01 Regulator openFDA |
|---|---|
| Octreotide | Class II recall, Ongoing, 2026-05-13 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.